OPNT
Wells Fargo’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-136,814
| Closed | -$2.77M | – | 7453 |
|
|
2022
Q4 | $2.77M | Sell |
136,814
-68,303
| -33% | -$1.39M | ﹤0.01% | 2388 |
|
|
2022
Q3 | $2.21M | Buy |
205,117
+1,886
| +0.9% | +$20.3K | ﹤0.01% | 2504 |
|
|
2022
Q2 | $2.44M | Sell |
203,231
-1,995
| -1% | -$23.9K | ﹤0.01% | 2499 |
|
|
2022
Q1 | $4.4M | Sell |
205,226
-19,071
| -9% | -$409K | ﹤0.01% | 2423 |
|
|
2021
Q4 | $7.54M | Sell |
224,297
-23,195
| -9% | -$780K | ﹤0.01% | 2016 |
|
|
2021
Q3 | $6.37M | Sell |
247,492
-3,515
| -1% | -$90.5K | ﹤0.01% | 2498 |
|
|
2021
Q2 | $3.36M | Buy |
251,007
+925
| +0.4% | +$12.4K | ﹤0.01% | 3091 |
|
|
2021
Q1 | $2.66M | Sell |
250,082
-2,123
| -0.8% | -$22.5K | ﹤0.01% | 3257 |
|
|
2020
Q4 | $2.03M | Buy |
252,205
+45,255
| +22% | +$363K | ﹤0.01% | 3446 |
|
|
2020
Q3 | $1.55M | Buy |
206,950
+95,414
| +86% | +$714K | ﹤0.01% | 3454 |
|
|
2020
Q2 | $1.01M | Buy |
111,536
+107,715
| +2,819% | +$973K | ﹤0.01% | 3722 |
|
|
2020
Q1 | $36K | Buy |
3,821
+21
| +0.6% | +$198 | ﹤0.01% | 5211 |
|
|
2019
Q4 | $55K | Hold |
3,800
| – | – | ﹤0.01% | 5240 |
|
|
2019
Q3 | $57K | Hold |
3,800
| – | – | ﹤0.01% | 5249 |
|
|
2019
Q2 | $50K | Hold |
3,800
| – | – | ﹤0.01% | 5259 |
|
|
2019
Q1 | $50K | Hold |
3,800
| – | – | ﹤0.01% | 5225 |
|
|
2018
Q4 | $55K | Buy |
3,800
+3,000
| +375% | +$43.4K | ﹤0.01% | 5207 |
|
|
2018
Q3 | $14K | Buy |
800
+700
| +700% | +$12.3K | ﹤0.01% | 5545 |
|
|
2018
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 5858 |
|
|
2018
Q1 | $2K | Sell |
100
-225
| -69% | -$4.5K | ﹤0.01% | 5782 |
|
|
2017
Q4 | $7K | Hold |
325
| – | – | ﹤0.01% | 5604 |
|
|
2017
Q3 | $12K | Buy |
+325
| New | +$12K | ﹤0.01% | 5491 |
|